摘要
Abstract
Objective:To investigate the efficacy of ergonovine maleate combined with uterotonin on postpartum haemorrhage due to lack of uterine contraction and to analyse its safety.Methods:100 cases of postpartum haemor-rhage with weak contraction were selected from January 2022 to December 2023,and were grouped by random num-ber table method,the control group(n=50)was treated with uterotonin,and the study group(n=50)was treated with ergonovine maleate,and the treatment effect,postpartum haemorrhage,coagulation function and adverse reac-tions of the two groups were compared and analysed.Results:The response rate in the study group was 96.00%,which was higher than 84.00%in the control group,P<0.05;the amount of post-partum haemorrhage in the study group at 2h,4h and 24h was(227.57±25.31)、(272.92±28.79)and(308.57±30.55)ml respectively,which were less than that in the control group,P<0.05;the PT after treatment in the study group(16.11±1.89)s、TT(20.23±2.42)s were longer than the control group,and FIB(2.22±0.25)g/L was lower than the control group,P<0.05;the rate of adverse reactions in the study group was 10.00%,which was not significant compared with the control group 12.00%,P<0.05.Conclusion:The efficacy of ergonovine maleate combined with oxytocin for postpartum haemorrhage in women with weak contraction is reliable,can significantly reduce the amount of post-partum haemorrhage,improve the coagulation function of women,and has fewer adverse reactions,which is worthy of clinical reference.关键词
马来酸麦角新碱/缩宫素/宫缩乏力/产后出血/凝血功能Key words
Ergonovine maleate/Oxytocin/Uterine atony/Postpartum hemorrhage/Coagulation function分类
临床医学
